Otello Stampacchia, Omega Funds

Otello Stampacchia is a life sciences investor who founded Omega Funds and focuses on venture capital in oncology, immunology. See contact routes.

About Otello Stampacchia

Otello Stampacchia is a life sciences investor who founded Omega Funds and focuses on venture capital in oncology, immunology, rare diseases, and precision medicine across the U.S. and Western Europe [1][4]. He leads stage-agnostic investments, primarily backing early Series A and B rounds as well as more mature biotechs, with the firm’s eighth fund totaling $647 million to invest in drug startups [3][4][5]. Notable portfolio companies include Adagio, Ikena, Kronos Bio, and Prevail (an Eli Lilly venture), reflecting Omega’s thesis of supporting companies addressing severe unmet medical needs and creating new therapeutics [4][5].

Otello Stampacchia at a glance

Role
Managing Director
Organization
Omega Funds
Location
Boston, Massachusetts, United States
Investor type
Venture Capital

Frequently asked about Otello Stampacchia

What does Otello Stampacchia invest in?
We have not verified a stated sector or stage focus for Otello Stampacchia at Omega Funds (Boston, Massachusetts, United States). The profile lists the organization, location and investors we track alongside them.
How do I contact Otello Stampacchia?
Otello Stampacchia's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Otello Stampacchia based?
Otello Stampacchia is based in Boston, Massachusetts, United States.

Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Boston.

Investors similar to Otello Stampacchia (20)

Browse related investor lists (2)

Compare Otello Stampacchia (8)

Investors like Otello Stampacchia · Full investor directory · Investor access · Company funding database